Skip to main content

Covista Inc.

For the period ended Oct 29, 2026. Filed Oct 29, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Oct 29, 2026 · Filed Oct 29, 2026

CVSA$110.32-2.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Adjusted EBITDA

Adjusted EBITDA

​​​​​​​​​​​​​
​ · ​ · Three Months Ended · ​
​ · ​ · September 30, · ​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Increase/(Decrease) · ​
​ · ​ · 2026 · ​ · 2025 · ​ · $ · ​ · % · ​
Chamberlain:​​​​​​​​​​​​
Adjusted operating income (GAAP)​$26,730​$25,608​$1,122​4.4%
Depreciation​​6,094​​5,375​​719​​​
Amortization of cloud computing implementation assets​​2,386​​1,527​​859​​​
Stock-based compensation​​2,372​​2,570​​(198)​​​
Adjusted EBITDA (non-GAAP)​$37,582​$35,080​$2,502​7.1%
Adjusted EBITDA margin (non-GAAP)​​19.5%​19.6%​​​​​
​​​​​​​​​​​​​
Walden:​​​​​​​​​​​​
Adjusted operating income (GAAP)​$65,043​$56,074​$8,969​16.0%
Depreciation​​1,784​​1,940​​(156)​​​
Amortization of cloud computing implementation assets​​2,253​​1,204​​1,049​​​
Stock-based compensation​​2,782​​2,653​​129​​​
Adjusted EBITDA (non-GAAP)​$71,862​$61,871​$9,991​16.1%
Adjusted EBITDA margin (non-GAAP)​​33.2%​32.6%​​​​​
​​​​​​​​​​​​​
Medical and Veterinary:​​​​​​​​​​​​
Adjusted operating income (GAAP)​$22,251​$16,772​$5,479​32.7%
Depreciation​​2,823​​2,820​​3​​​
Amortization of cloud computing implementation assets​​931​​411​​520​​​
Stock-based compensation​​1,390​​1,410​​(20)​​​
Adjusted EBITDA (non-GAAP)​$27,395​$21,413​$5,982​27.9%
Adjusted EBITDA margin (non-GAAP)​​26.7%​23.0%​​​​​
​​​​​​​​​​​​​
Covista(1):​​​​​​​​​​​​
Net income (GAAP)​$67,427​$61,832​$5,595​9.0%
Loss (income) from discontinued operations​​4,055​​(770)​​4,825​​​
Interest expense​​9,944​​11,090​​(1,146)​​​
Other income, net​​(1,416)​​(2,486)​​1,070​​​
Provision for income taxes​​18,017​​15,811​​2,206​​​
Depreciation and amortization​​17,826​​16,243​​1,583​​​
Stock-based compensation​​8,181​​8,293​​(112)​​​
Restructuring expense​​163​​310​​(147)​​​
Strategic advisory costs​​6,231​​1,684​​4,547​​​
Debt modification costs​​756​​—​​756​​​
Adjusted EBITDA (non-GAAP)​$131,184​$112,007​$19,177​17.1%
Adjusted EBITDA margin (non-GAAP)​​25.6%​24.2%​​​​​

(1) Consolidated results include Home Office activities not allocated to segments.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.